Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity
Tamer B. Shabaneh, Andrew R. Stevens, Sylvia M. Stull, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 2, pp. e008566-e008566
Open Access | Times Cited: 10

Showing 10 citing articles:

Beyond Chemoimmunotherapy in Advanced Non–Small Cell Lung Cancer: New Frontiers, New Challenges
Giannis Mountzios, Jarushka Naidoo, Chao Wang, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 9
Universal CAR 2.0 to overcome current limitations in CAR therapy
Lara Sophie Schlegel, Coralie Werbrouck, Michael Boettcher, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Single-chain variable fragment affinity tuning can optimize anti-AML CAR-NK cell functionality
Ruyan Rahnama, Monika Kizerwetter, Yang Huilin, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e010763-e010763
Open Access
Human Embryonic Kidney HEK293 Cells as a Model to Study SMVT-Independent Transport of Biotin and Biotin-Furnished Nanoparticles in Targeted Therapy
Magdalena Twardowska, Andrzej Łyskowski, Maria Misiorek, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1594-1594
Open Access
The paths toward immunotherapy of esophageal cancer: An overview of clinical trials
Azfar Jamal, Allolo D Aldreiwish, Saeed Banawas, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114261-114261
Closed Access
Expanding the Therapeutic Reach of Chimeric Antigen Receptor T-Cells and Bispecific T-Cell Engagers Across Solid Tumors
William K Gerber, Yiyu Xie, Shyam A. Patel
JCO Precision Oncology (2025), Iss. 9
Closed Access
Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells
Guangyu Zhou, Shengyu Fu, Yunsen Zhang, et al.
Antibodies (2024) Vol. 13, Iss. 2, pp. 45-45
Open Access | Times Cited: 1
Enhancing antitumor response by efficiently generating large-scale TCR-T cells targeting a single epitope across multiple cancer antigens
Obed Boadi Amissah, Rajesh Basnet, Wenfang Chen, et al.
Cellular Immunology (2024) Vol. 399-400, pp. 104827-104827
Closed Access
CAR-T Cells in the Treatment of Nervous System Tumors
Ugo Testa, Germana Castelli, Elvira Pelosi
Cancers (2024) Vol. 16, Iss. 16, pp. 2913-2913
Open Access
Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell function
Markus Barden, Patrick Ronan Elsenbroich, Vivian Haas, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 12, pp. e010208-e010208
Open Access
Page 1

Scroll to top